mHealth Patient Adoption: Gaps Watchdogs Must Fix
New peer-reviewed studies expose mHealth patient adoption barriers—from literacy gaps to wearable distrust—that regulators and providers have yet to address.
Telehealth News Network
Newest first — how to get care online, and how to tell the trustworthy providers from the rest.
New peer-reviewed studies expose mHealth patient adoption barriers—from literacy gaps to wearable distrust—that regulators and providers have yet to address.
Mobile health coaching shows real results—but retention failures, equity gaps, and weak oversight put vulnerable groups at risk. What the data show.
New research exposes cardiac stress test accuracy failures between local sites and core labs. Here's what patients and watchdogs need to know.
Telehealth coverage gaps shift costs onto patients in Ghana, the U.S., and beyond. A watchdog review of seven studies shows who pays when systems fail.
Telehealth documentation failures across neurology, opioid care, and drug prescribing expose patients to serious risk. Here's what the research shows.
Home treatment safety gaps in chemotherapy, ICU monitoring, and at-home diagnostics demand urgent oversight. What new research reveals.
New research exposes telehealth intensity gaps in stroke rehab, heart failure, and mental health. What patients and watchdogs need to know.
New peer-reviewed research exposes who is being left behind by IoT health adoption—and why literacy, trust, and design failures are the core problems.
eHealth lifestyle programs show real results—but retention failures, equity gaps, and weak oversight leave key populations behind. Here's what the data show.
New research exposes where COPD digital tools fall short for rural and underserved patients—and what watchdogs, clinicians, and policymakers must do next.
New research exposes telehealth insurance gaps hitting Medicaid patients, dementia caregivers, and rehab patients hardest. Here's what the data show.
New research exposes telehealth prescribing blind spots across opioid therapy, ketamine, peptides, and PrEP. Here's what regulators and patients need to know.
New peer-reviewed research exposes home-based care safety gaps in chemotherapy, remote monitoring, and at-home diagnostics. Here's what watchdogs found.
Medicaid telehealth gaps are cutting off undocumented, neurology, and palliative care patients. New research shows who loses access and why.
New research exposes mHealth safety gaps in cancer, dementia, and IoT care. Watchdogs must act now to protect vulnerable patients. Not medical advice.
New research on eHealth nutrition programs reveals critical gaps in equity, retention, and oversight. Here's what watchdogs and consumers need to know.
Chronic disease telehealth shows real promise but critical gaps in literacy, access, and oversight threaten longevity outcomes. Here's what the data reveal.
Telehealth payment models leave patients facing hidden costs and uneven coverage. A watchdog look at what the latest research reveals about reimbursement gaps.
Telehealth drug oversight has critical gaps. A watchdog report examines state-level inconsistencies, liability risks, and documentation failures across the U.S.
Telehealth scaling is accelerating, but new research exposes oversight gaps in AI care, home chemo, rural access, and at-home testing. What watchdogs must act on.
New research reveals telehealth equity gaps in access, rehab, and cost. Learn what the data show and why oversight matters. Not medical advice.
New research reveals critical mHealth oversight gaps in equity, safety, and regulation. What watchdogs and clinicians need to know now.
Digital fitness programs promise results, but new research reveals critical gaps in equity, retention, and oversight. What the data really show.
Telehealth gaps in chronic disease care threaten longevity. New research exposes barriers in COPD, diabetes, heart failure, and more. Read the watchdog report.
Telehealth reimbursement rules vary wildly by payer and country. New research exposes coverage gaps harming patients. Learn what the data reveal.
Telehealth drug rules vary wildly by state, leaving patients exposed. A watchdog look at the regulatory gaps research says demand urgent fixes.
Telehealth expansion is accelerating, but new research exposes oversight gaps in AI care, home chemo, and rural access. What watchdogs need to know.
New research exposes telehealth access gaps affecting veterans, rural patients, and women. Learn what the data reveal and how care delivery can improve.
A watchdog look at telehealth oversight gaps—from patient safety concerns to equity issues—grounded in recent peer-reviewed research. Not medical advice.
Digital nutrition programs show promise, but new research exposes key gaps in access, retention, and outcomes. What the evidence really says.
Telehealth literacy gaps put rural and aging patients at risk. New research reveals what providers and policymakers must fix now.
A watchdog look at telehealth cost and insurance gaps—from Medicaid access failures to global reimbursement models—and what the research says needs to change.
Telehealth regulation lags behind rapid growth. New research reveals documentation failures, liability blind spots, and uneven state oversight threatening patients.
Telehealth oversight gaps put patients at risk. New research exposes safety, equity, and documentation failures across virtual care models. Not medical advice.
New telehealth outcomes research reveals what works, what gaps remain, and what patients should ask before starting virtual care. Not medical advice.
A telehealth watchdog report examines equity, safety, and trust gaps revealed by recent peer-reviewed research. Not medical advice.
Digital nutrition programs promise big results, but what does the research actually show? Our watchdog report breaks down the evidence for general audiences.
Telehealth promises longer, healthier lives—but rural and underserved populations still face critical access gaps. A watchdog look at the evidence.
Telehealth reimbursement gaps leave patients paying more or going without care. See what the research reveals about cost and insurance failures.
Telehealth regulation gaps let unvetted drugs reach patients with little oversight. See what watchdog research reveals and why experts urge reform.
Telehealth expands fast, but who ensures patient safety? Our watchdog report examines oversight gaps across virtual care, home testing, and AI models.
Telehealth results vary by condition. Our watchdog report examines the latest research on virtual care outcomes so you can ask smarter questions.
For a while, drug shortages made compounded semaglutide widely available online. When the FDA declared the shortages over, the legal ground shifted under those products.
A telehealth visit can end with a semaglutide prescription in minutes. Here's what a legitimate process looks like — and where the shortcuts should worry you.
Most telehealth weight-loss providers are legitimate. These are the warning signs that separate a real clinic from a subscription trap.
Rapid weight loss burns lean mass, not just fat. Here is what medical societies say about protein, and how to tell if your online provider actually counsels it.
Telehealth longevity clinics sell tests, peptides, and off-label prescriptions with the promise of more years. Here's how to read the menu with a clear head.
The telehealth weight-loss market splits into a few distinct business models. Knowing which kind you're buying from tells you a lot about legitimacy, cost, and recourse.
Direct cash prices have dropped fast, insurance for weight loss is a coin flip, and telehealth platforms stack their own fees on top. Here's how to compare the real number.
The doctor treating you online must hold a license where you sit, not where the company is based. Here is how to check it yourself in five minutes.
The clinician who prescribes to you online generally must be licensed in YOUR state — not theirs. Here's how cross-state rules, compacts and the DEA extension really work.
Which peptides a clinic can actually prescribe, which are sold as 'research chemicals not for human use,' and the red flags that separate a real provider from a gray-market storefront.
That $99 online weight-loss plan often isn't the whole bill. Here's how recurring telehealth billing works, what the law now requires, and how to avoid subscription traps.
Combining fasting with an online-prescribed GLP-1 raises hypoglycemia, dehydration and nausea questions the intake form may never ask. Here's the access-side gap.
Epigenetic clocks and biomarker panels ship to your door for $200-$600. Here's who runs the labs, what the evidence supports, and how to read the marketing.